CompaniesParvus Therapeutics
Parvus Therapeutics logo

Parvus Therapeutics

active
South SF, CA, United States
Founded 2009
Website
About

Peptide-MHC-coated nanoparticles

Areas of Focus

Categories

NanotechBiologics & BiopharmaceuticalBiotech
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

24

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
Today
Hover over trial bars to see details

Recent Trials

NCT06798454Lead Sponsor
Single Ascending Dose Study to Evaluate Safety Tolerability, Pharmacokinetics, and Pharmacodynamics of PVT201 in Healthy Subjects and Patients (PBC/PSC)
PHASE1Completed
24 participants
Started: Oct 15, 2024 · Completed: Apr 23, 2025
Locations (1)
Headquarters
South SF, CA, United States
Map

Loading map...